GBP5 Expression Predicted Prognosis of Immune Checkpoint Inhibitors in Small Cell Lung Cancer and Correlated with Tumor Immune Microenvironment

BACKGROUND: The discovery and development of immune checkpoint inhibitors (ICIs) has significantly enhanced the arsenal of immunotherapy treatments available for cancer patients. The identification of biomarkers that are indicative of an individual’s sensitivity to treatment with ICIs is useful for...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Qin, Li, Deyu, Yin, Yan, Cheng, Lifang, Ouyang, Shuming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518156/
https://www.ncbi.nlm.nih.gov/pubmed/37750170
http://dx.doi.org/10.2147/JIR.S401430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518156/
https://www.ncbi.nlm.nih.gov/pubmed/37750170
http://dx.doi.org/10.2147/JIR.S401430

Ejemplares similares